AU2004299341A1 - System - Google Patents

System Download PDF

Info

Publication number: AU2004299341A1
Authority: AU; Australia
Prior art keywords: microfluidic; sample; assay; size exclusion; fluid
Prior art date: 2003-12-17
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2004299341A

Other languages

English (en)

Inventor

Simon Burnell

Victor Manneh

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Alere Switzerland GmbH

Original Assignee

Inverness Medical Switzerland GmbH

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-12-17

Filing date

2004-12-17

Publication date

2005-06-30

2003-12-17 Priority claimed from GBGB0329220.8A external-priority patent/GB0329220D0/en

2004-12-17 Application filed by Inverness Medical Switzerland GmbH filed Critical Inverness Medical Switzerland GmbH

2005-06-30 Publication of AU2004299341A1 publication Critical patent/AU2004299341A1/en

Status Abandoned legal-status Critical Current

Links

238000003556 assay Methods 0.000 claims description 83
239000012530 fluid Substances 0.000 claims description 67
230000007717 exclusion Effects 0.000 claims description 55
238000000926 separation method Methods 0.000 claims description 49
239000003795 chemical substances by application Substances 0.000 claims description 43
230000002776 aggregation Effects 0.000 claims description 39
238000004220 aggregation Methods 0.000 claims description 39
238000001514 detection method Methods 0.000 claims description 25
239000012491 analyte Substances 0.000 claims description 23
230000037361 pathway Effects 0.000 claims description 22
238000004891 communication Methods 0.000 claims description 16
210000004369 blood Anatomy 0.000 claims description 14
239000008280 blood Substances 0.000 claims description 14
238000000034 method Methods 0.000 claims description 11
230000015572 biosynthetic process Effects 0.000 claims description 10
238000005755 formation reaction Methods 0.000 claims description 10
230000027455 binding Effects 0.000 claims description 9
238000000159 protein binding assay Methods 0.000 claims description 7
238000011144 upstream manufacturing Methods 0.000 claims description 7
239000003153 chemical reaction reagent Substances 0.000 claims description 5
108090001090 Lectins Proteins 0.000 claims description 3
102000004856 Lectins Human genes 0.000 claims description 3
230000007274 generation of a signal involved in cell-cell signaling Effects 0.000 claims description 3
230000003993 interaction Effects 0.000 claims description 3
239000002523 lectin Substances 0.000 claims description 3
230000026683 transduction Effects 0.000 claims description 3
238000010361 transduction Methods 0.000 claims description 3
229920002307 Dextran Polymers 0.000 claims description 2
210000004027 cell Anatomy 0.000 description 35
239000002245 particle Substances 0.000 description 24
210000003743 erythrocyte Anatomy 0.000 description 20
239000000758 substrate Substances 0.000 description 16
MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 10
230000005284 excitation Effects 0.000 description 7
108090000790 Enzymes Proteins 0.000 description 6
102000004190 Enzymes Human genes 0.000 description 6
230000003287 optical effect Effects 0.000 description 6
230000009870 specific binding Effects 0.000 description 6
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 5
239000002585 base Substances 0.000 description 5
238000003018 immunoassay Methods 0.000 description 5
238000005259 measurement Methods 0.000 description 5
229910052760 oxygen Inorganic materials 0.000 description 5
239000001301 oxygen Substances 0.000 description 5
230000009471 action Effects 0.000 description 4
239000011324 bead Substances 0.000 description 4
239000000463 material Substances 0.000 description 4
108090000765 processed proteins & peptides Proteins 0.000 description 4
102000004169 proteins and genes Human genes 0.000 description 4
108090000623 proteins and genes Proteins 0.000 description 4
239000000126 substance Substances 0.000 description 4
230000004520 agglutination Effects 0.000 description 3
239000011230 binding agent Substances 0.000 description 3
230000008859 change Effects 0.000 description 3
238000006243 chemical reaction Methods 0.000 description 3
150000001875 compounds Chemical class 0.000 description 3
239000000975 dye Substances 0.000 description 3
IEQIEDJGQAUEQZ-UHFFFAOYSA-N phthalocyanine Chemical compound N1C(N=C2C3=CC=CC=C3C(N=C3C4=CC=CC=C4C(=N4)N3)=N2)=C(C=CC=C2)C2=C1N=C1C2=CC=CC=C2C4=N1 IEQIEDJGQAUEQZ-UHFFFAOYSA-N 0.000 description 3
229920003023 plastic Polymers 0.000 description 3
239000004417 polycarbonate Substances 0.000 description 3
229920000515 polycarbonate Polymers 0.000 description 3
238000002203 pretreatment Methods 0.000 description 3
230000035945 sensitivity Effects 0.000 description 3
241000894007 species Species 0.000 description 3
238000012546 transfer Methods 0.000 description 3
YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
108010074051 C-Reactive Protein Proteins 0.000 description 2
102100032752 C-reactive protein Human genes 0.000 description 2
102000012673 Follicle Stimulating Hormone Human genes 0.000 description 2
108010079345 Follicle Stimulating Hormone Proteins 0.000 description 2
XJLXINKUBYWONI-DQQFMEOOSA-N [[(2r,3r,4r,5r)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2s,3r,4s,5s)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate Chemical compound NC(=O)C1=CC=C[N+]([C@@H]2[C@H]([C@@H](O)[C@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-DQQFMEOOSA-N 0.000 description 2
239000000872 buffer Substances 0.000 description 2
150000001720 carbohydrates Chemical class 0.000 description 2
235000014633 carbohydrates Nutrition 0.000 description 2
-1 chromogens Substances 0.000 description 2
238000002474 experimental method Methods 0.000 description 2
239000000706 filtrate Substances 0.000 description 2
229940028334 follicle stimulating hormone Drugs 0.000 description 2
239000012634 fragment Substances 0.000 description 2
230000005283 ground state Effects 0.000 description 2
239000005556 hormone Substances 0.000 description 2
229940088597 hormone Drugs 0.000 description 2
238000002156 mixing Methods 0.000 description 2
230000007193 modulation by symbiont of host erythrocyte aggregation Effects 0.000 description 2
229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 2
239000008055 phosphate buffer solution Substances 0.000 description 2
239000004033 plastic Substances 0.000 description 2
102000004196 processed proteins & peptides Human genes 0.000 description 2
238000005086 pumping Methods 0.000 description 2
108090001008 Avidin Proteins 0.000 description 1
241000894006 Bacteria Species 0.000 description 1
208000006386 Bone Resorption Diseases 0.000 description 1
108020004635 Complementary DNA Proteins 0.000 description 1
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
YPZRHBJKEMOYQH-UYBVJOGSSA-N FADH2 Chemical compound C1=NC2=C(N)N=CN=C2N1[C@@H]([C@H](O)[C@@H]1O)O[C@@H]1COP(O)(=O)OP(O)(=O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C(NC(=O)NC2=O)=C2NC2=C1C=C(C)C(C)=C2 YPZRHBJKEMOYQH-UYBVJOGSSA-N 0.000 description 1
108020001621 Natriuretic Peptide Proteins 0.000 description 1
102000004571 Natriuretic peptide Human genes 0.000 description 1
102100027378 Prothrombin Human genes 0.000 description 1
108010094028 Prothrombin Proteins 0.000 description 1
102000013394 Troponin I Human genes 0.000 description 1
108010065729 Troponin I Proteins 0.000 description 1
102000004987 Troponin T Human genes 0.000 description 1
108090001108 Troponin T Proteins 0.000 description 1
241000700605 Viruses Species 0.000 description 1
238000002835 absorbance Methods 0.000 description 1
239000002253 acid Substances 0.000 description 1
150000007513 acids Chemical class 0.000 description 1
239000000853 adhesive Substances 0.000 description 1
230000001070 adhesive effect Effects 0.000 description 1
150000001413 amino acids Chemical class 0.000 description 1
239000000427 antigen Substances 0.000 description 1
108091007433 antigens Proteins 0.000 description 1
102000036639 antigens Human genes 0.000 description 1
229960002685 biotin Drugs 0.000 description 1
235000020958 biotin Nutrition 0.000 description 1
239000011616 biotin Substances 0.000 description 1
210000001124 body fluid Anatomy 0.000 description 1
230000024279 bone resorption Effects 0.000 description 1
230000000747 cardiac effect Effects 0.000 description 1
239000003054 catalyst Substances 0.000 description 1
238000005119 centrifugation Methods 0.000 description 1
229960004407 chorionic gonadotrophin Drugs 0.000 description 1
238000005345 coagulation Methods 0.000 description 1
230000015271 coagulation Effects 0.000 description 1
239000011248 coating agent Substances 0.000 description 1
238000000576 coating method Methods 0.000 description 1
230000000295 complement effect Effects 0.000 description 1
231100000673 dose–response relationship Toxicity 0.000 description 1
239000003814 drug Substances 0.000 description 1
229940079593 drug Drugs 0.000 description 1
239000012636 effector Substances 0.000 description 1
239000003344 environmental pollutant Substances 0.000 description 1
239000002532 enzyme inhibitor Substances 0.000 description 1
108010014507 erythroagglutinating phytohemagglutinin Proteins 0.000 description 1
PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
239000010931 gold Substances 0.000 description 1
229910052737 gold Inorganic materials 0.000 description 1
238000005534 hematocrit Methods 0.000 description 1
230000005660 hydrophilic surface Effects 0.000 description 1
230000002209 hydrophobic effect Effects 0.000 description 1
238000011534 incubation Methods 0.000 description 1
238000002347 injection Methods 0.000 description 1
239000007924 injection Substances 0.000 description 1
238000001746 injection moulding Methods 0.000 description 1
230000001788 irregular Effects 0.000 description 1
239000004816 latex Substances 0.000 description 1
229920000126 latex Polymers 0.000 description 1
210000000265 leukocyte Anatomy 0.000 description 1
230000004576 lipid-binding Effects 0.000 description 1
150000002632 lipids Chemical class 0.000 description 1
230000001592 luteinising effect Effects 0.000 description 1
239000002207 metabolite Substances 0.000 description 1
239000013528 metallic particle Substances 0.000 description 1
244000005700 microbiome Species 0.000 description 1
239000000203 mixture Substances 0.000 description 1
238000012544 monitoring process Methods 0.000 description 1
210000004898 n-terminal fragment Anatomy 0.000 description 1
239000000692 natriuretic peptide Substances 0.000 description 1
BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 1
239000004745 nonwoven fabric Substances 0.000 description 1
238000002414 normal-phase solid-phase extraction Methods 0.000 description 1
108020004707 nucleic acids Proteins 0.000 description 1
102000039446 nucleic acids Human genes 0.000 description 1
150000007523 nucleic acids Chemical class 0.000 description 1
150000002894 organic compounds Chemical class 0.000 description 1
239000013618 particulate matter Substances 0.000 description 1
239000000575 pesticide Substances 0.000 description 1
231100000719 pollutant Toxicity 0.000 description 1
229920002635 polyurethane Polymers 0.000 description 1
239000004814 polyurethane Substances 0.000 description 1
238000011045 prefiltration Methods 0.000 description 1
229940039716 prothrombin Drugs 0.000 description 1
230000002285 radioactive effect Effects 0.000 description 1
238000005070 sampling Methods 0.000 description 1
238000007650 screen-printing Methods 0.000 description 1
150000003431 steroids Chemical class 0.000 description 1
230000003746 surface roughness Effects 0.000 description 1
239000004094 surface-active agent Substances 0.000 description 1
238000012360 testing method Methods 0.000 description 1
239000003053 toxin Substances 0.000 description 1
231100000765 toxin Toxicity 0.000 description 1
108700012359 toxins Proteins 0.000 description 1
230000000007 visual effect Effects 0.000 description 1
239000011782 vitamin Substances 0.000 description 1
229940088594 vitamin Drugs 0.000 description 1
229930003231 vitamin Natural products 0.000 description 1
235000013343 vitamin Nutrition 0.000 description 1
238000003466 welding Methods 0.000 description 1

Classifications

- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/34—Purifying; Cleaning
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
- B01L3/502746—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by the means for controlling flow resistance, e.g. flow controllers, baffles
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
- B01L3/502753—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by bulk separation arrangements on lab-on-a-chip devices, e.g. for filtration or centrifugation
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
- B01L2200/06—Fluid handling related problems
- B01L2200/0647—Handling flowable solids, e.g. microscopic beads, cells, particles
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/06—Auxiliary integrated devices, integrated components
- B01L2300/0681—Filter
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0809—Geometry, shape and general structure rectangular shaped
- B01L2300/0816—Cards, e.g. flat sample carriers usually with flow in two horizontal directions
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2400/00—Moving or stopping fluids
- B01L2400/04—Moving fluids with specific forces or mechanical means
- B01L2400/0403—Moving fluids with specific forces or mechanical means specific forces
- B01L2400/0406—Moving fluids with specific forces or mechanical means specific forces capillary forces
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2400/00—Moving or stopping fluids
- B01L2400/04—Moving fluids with specific forces or mechanical means
- B01L2400/0475—Moving fluids with specific forces or mechanical means specific mechanical means and fluid pressure
- B01L2400/0487—Moving fluids with specific forces or mechanical means specific mechanical means and fluid pressure fluid pressure, pneumatics
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2400/00—Moving or stopping fluids
- B01L2400/08—Regulating or influencing the flow resistance
- B01L2400/084—Passive control of flow resistance
- B01L2400/086—Passive control of flow resistance using baffles or other fixed flow obstructions
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/01—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials specially adapted for biological cells, e.g. blood cells
- G01N2015/012—Red blood cells

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Analytical Chemistry (AREA)
General Health & Medical Sciences (AREA)
Dispersion Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Clinical Laboratory Science (AREA)
Molecular Biology (AREA)
Hematology (AREA)
Biochemistry (AREA)
Immunology (AREA)
Pathology (AREA)
General Physics & Mathematics (AREA)
Physics & Mathematics (AREA)
Biomedical Technology (AREA)
Engineering & Computer Science (AREA)
Investigating Or Analysing Biological Materials (AREA)
Automatic Analysis And Handling Materials Therefor (AREA)

AU2004299341A 2003-12-17 2004-12-17 System Abandoned AU2004299341A1 (en)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
GB0329220.8		2003-12-17
GBGB0329220.8A GB0329220D0 (en)	2003-12-17	2003-12-17	System
US55327504P	2004-03-15	2004-03-15
US60/553,275		2004-03-15
PCT/GB2004/005334 WO2005058500A1 (en)	2003-12-17	2004-12-17	System

Publications (1)

Publication Number	Publication Date
AU2004299341A1 true AU2004299341A1 (en)	2005-06-30

Family

ID=34702514

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2004299341A Abandoned AU2004299341A1 (en)	2003-12-17	2004-12-17	System

Country Status (5)

Country	Link
EP (1)	EP1691925A1 (ja)
JP (1)	JP2007519896A (ja)
AU (1)	AU2004299341A1 (ja)
CA (1)	CA2549094A1 (ja)
WO (1)	WO2005058500A1 (ja)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2008256458A (ja) *	2007-04-03	2008-10-23	Olympus Corp	凝集判定容器およびそれを用いた凝集判定方法
KR101253391B1 (ko)	2007-11-29	2013-04-11	인터내셔널 비지네스 머신즈 코포레이션	표본 내 분석물을 검출하기 위한 장치 및 방법
WO2013158044A1 (en) *	2012-04-20	2013-10-24	Agency For Science, Technology And Research	Apparatus and method for separating a biological entity from a sample volume
EP3014243B1 (en) *	2013-06-25	2022-02-16	University of Washington through its Center for Commercialization	Self-digitization of sample volumes
AU2014352822B2 (en) *	2013-11-22	2019-06-20	The General Hospital Corporation	Microfluidic methods and systems for isolating particle clusters
US10996216B2 (en)	2015-02-27	2021-05-04	Toppan Printing Co., Ltd.	Method for separating cells, and device therefor
US10859563B2 (en) *	2015-12-01	2020-12-08	General Electric Company	Erythrocyte aggregation and leukocyte isolation
US11604148B2 (en) *	2017-02-09	2023-03-14	Essenlix Corporation	Colorimetric assays
US20210170396A1 (en) *	2018-01-16	2021-06-10	Hewlett-Packard Development Company, L.P.	Fluid testing
JP7202820B2 (ja) *	2018-09-12	2023-01-12	株式会社フコク	マイクロ流路チップ
DE102019102822A1 (de) *	2019-02-05	2020-08-06	Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V.	Mikrofluidikeinrichtung und Verfahren zum Abtrennen von Blutserum

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4753776A (en) *	1986-10-29	1988-06-28	Biotrack, Inc.	Blood separation device comprising a filter and a capillary flow pathway exiting the filter
US5766552A (en) *	1993-04-20	1998-06-16	Actimed Laboratories, Inc.	Apparatus for red blood cell separation
WO2001024931A1 (en) *	1999-10-05	2001-04-12	Roche Diagnostic Gmbh	Capillary device for separating undesired components from a liquid sample and related method
JP4733331B2 (ja) *	2000-03-14	2011-07-27	マイクロニックス、インコーポレーテッド	マイクロ流動体分析用デバイス
US6599480B1 (en) *	2000-09-27	2003-07-29	Becton, Dickinson And Company	Apparatus for obtaining increased particle concentration for optical examination
US20020160518A1 (en) *	2001-04-03	2002-10-31	Hayenga Jon W.	Microfluidic sedimentation

2004
- 2004-12-17 WO PCT/GB2004/005334 patent/WO2005058500A1/en not_active Application Discontinuation
- 2004-12-17 EP EP04806136A patent/EP1691925A1/en not_active Withdrawn
- 2004-12-17 AU AU2004299341A patent/AU2004299341A1/en not_active Abandoned
- 2004-12-17 CA CA002549094A patent/CA2549094A1/en not_active Abandoned
- 2004-12-17 JP JP2006544556A patent/JP2007519896A/ja not_active Withdrawn

Also Published As

Publication number	Publication date
EP1691925A1 (en)	2006-08-23
JP2007519896A (ja)	2007-07-19
WO2005058500A1 (en)	2005-06-30
CA2549094A1 (en)	2005-06-30

Legal Events

Date	Code	Title	Description
2008-05-15	MK1	Application lapsed section 142(2)(a) - no request for examination in relevant period

Publication	Publication Date	Title
US6297061B1 (en)	2001-10-02	Simultaneous particle separation and chemical reaction
US9164091B2 (en)	2015-10-20	Centrifugal micro-fluidic device and method for detecting analytes from liquid specimen
AU770913B2 (en)	2004-03-04	Devices, systems and methods for time domain multiplexing of reagents
CA1310566C (en)	1992-11-24	Element and method for performing biological assays accurately, rapidlyand simply
EP2715357B1 (en)	2015-11-04	Microfluidic disc for use in with bead-based immunoassays
EP2864781B1 (en)	2017-12-13	A method and a system for quantitative or qualitative determination of a target component
US20060018797A1 (en)	2006-01-26	Microfluidic separation of particles from fluid
US20030124623A1 (en)	2003-07-03	Microfluidic device and surface decoration process for solid phase affinity binding assays
US20070122819A1 (en)	2007-05-31	Analyte assay structure in microfluidic chip for quantitative analysis and method for using the same
JP2003114229A (ja)	2003-04-18	マイクロチャネルチップ，マイクロチャネルチップを使用した測定装置及び測定方法
CN111013677B (zh)	2022-07-08	微流控芯片、检测装置以及检测方法
AU2004299341A1 (en)	2005-06-30	System
GB2423266A (en)	2006-08-23	A structure and method for detecting an analyte in a microfluidic chip
CN113967486A (zh)	2022-01-25	离心式微流控芯片
JP2003075444A (ja)	2003-03-12	測定対象物の測定用チップ，測定対象物の測定装置及び測定対象物の測定方法
Torul et al.	2023	Microfluidic-based blood immunoassays
JP2002122597A (ja)	2002-04-26	測定対象物の測定用チップ，測定対象物の測定装置及び測定対象物の測定方法
Sen et al.	2022	Microfluidics-Based Point-of-Care Diagnostic Devices
CN111632631B (zh)	2022-10-04	微流控基板、微流控装置及流体驱动方法
JP2003098175A (ja)	2003-04-03	測定対象物の測定用チップ，測定対象物の測定装置及び測定対象物の測定方法